Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Koh

Showing results (281-290 of 283) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 283 results.
Sustainability Science|September 4, 2018
Research priorities for managing the impacts and dependencies of business upon food, energy, water and the environmentJonathan M H Green, Gemma R Cranston, William J Sutherland, et al.
The Lancet. Rheumatology|May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trialCarl S Goodyear, Amit Patel, Eleanor Barnes, et al.
Transplantation and Cellular Therapy|December 26, 2022
An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid LeukemiaMolly C Tokaz, Helen Baldomero, Andrew J Cowan, et al.
Pageof 29

Showing results (281-290 of 283) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 283 results.
Sustainability Science|September 4, 2018
Research priorities for managing the impacts and dependencies of business upon food, energy, water and the environmentJonathan M H Green, Gemma R Cranston, William J Sutherland, et al.
The Lancet. Rheumatology|May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trialCarl S Goodyear, Amit Patel, Eleanor Barnes, et al.
Transplantation and Cellular Therapy|December 26, 2022
An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid LeukemiaMolly C Tokaz, Helen Baldomero, Andrew J Cowan, et al.
Pageof 29